Sino BiologicalInc Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Zhang Jie
Chief executive officer
CN¥2.7m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.9yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Sino BiologicalInc's (SZSE:301047) Shareholders Have More To Worry About Than Only Soft Earnings
Nov 04
Sino Biological,Inc.'s (SZSE:301047) Shares Climb 31% But Its Business Is Yet to Catch Up
Sep 30Sino BiologicalInc (SZSE:301047) Is Paying Out A Dividend Of CN¥2.00
May 21Sino Biological,Inc.'s (SZSE:301047) P/E Is Still On The Mark Following 26% Share Price Bounce
May 08Beyond Lackluster Earnings: Potential Concerns For Sino BiologicalInc's (SZSE:301047) Shareholders
May 06CEO
Zhang Jie (51 yo)
6.9yrs
Tenure
CN¥2,740,800
Compensation
Mr. Zhang Jie, Ph D, serves as R&D Director of Sino Biological Inc. He is General Manager of Sino Biological Inc since 2018 and is its MD & Director. Mr. Zhang graduated from Beijing Medical Sciences Unive...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM, MD, R&D Director & Director | 4.8yrs | CN¥2.74m | no data | |
| CFO, Secretary to the Board & Non-Independent Director | 4.8yrs | CN¥1.20m | no data | |
| Founder | 4.8yrs | no data | 55.81% CN¥ 4.3b | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Non-Independent Director | 4.8yrs | no data | no data | |
| Non-Independent Director | 1.8yrs | no data | no data | |
| Non-Independent Director | 4.8yrs | no data | no data | |
| Independent Director | 4.8yrs | CN¥120.00k | no data | |
| Independent Director | 4.8yrs | CN¥120.00k | no data | |
| Independent Director | 1.8yrs | CN¥90.00k | no data | |
| Chairman of the Supervisory Board | 4.8yrs | no data | no data | |
| Supervisor | 1.3yrs | no data | no data |
4.8yrs
Average Tenure
51yo
Average Age
Experienced Board: 301047's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 01:23 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sino Biological,Inc. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiaying Fu | China International Capital Corporation Limited |
| Zhu Chen | Citic Securities Co., Ltd. |
| Kai Wang | Citic Securities Co., Ltd. |